IMPALA is pleased to share our latest work product "Data Analytics for Quality Assurance in Pharmaceutical Development Framework," which offers insights and guidance on transforming Quality Assurance (QA) in Good Clinical Practice (GCP) and Good Pharmacovigilance Practice (GVP) through the [...]
The Drug Information Association (DIA) Global Annual Meeting held in San Diego from June 17-20, 2024, brought together professionals from the pharmaceutical industry, regulatory agencies, and research organizations. We were lucky to have a great delegation of IMPALA (Inter coMPany [...]
The DIA China Meeting held in SuZhou from May 17-19, 2024, brought together professionals from the pharmaceutical industry, regulatory agencies, and research organisations. IMPALA was grateful to present at two sessions to showcase some of the work products the consortium [...]
The recording from the May 6th, 2024 Webinar on Identifying Anomalies in Clinical Trial Data with CTAS (Clinical Trial Anomaly Spotter) is now available. During this presentation, Pekka Tiikkainen (Bayer) provided an overview of the open-source R Package that identifies [...]
{simaerep} was originally developed to detect sites that are under-reporting Adverse Events (AE) in clinical trials using a nonparametric bootstrap algorithm. With the release of the most current version v0.5.0 {simaerep} can also be used to detect over-reporting. With this [...]
